SINGAPORE -- German pharmaceutical company BioNTech plans to set up a vaccine manufacturing facility in Singapore as early as 2023 to meet future demand in Southeast Asia, the company announced Monday.
COVID vaccines
BioNTech to produce vaccine in Singapore, as it expands in Asia
Production to start in 2023 in meet regional demand in case of future pandemics
BioNTech is starting to expand its footprint in Asia, spurred on by the COVID-19 pandemic. © Reuters
Read Next
Latest on COVID vaccines
